NasdaqCM - Nasdaq Real Time Price USD
Jaguar Health, Inc. (JAGX)
11.87
-0.37
(-3.02%)
At close: May 1 at 4:00:01 PM EDT
12.30
+0.43
+(3.62%)
After hours: May 1 at 7:57:58 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,970,372 | 60 |
| Sales | 326,059 | 2 |
| Net Shares Purchased (Sold) | 1,644,313 | 62 |
| Total Insider Shares Held | 97.19k | -- |
| % Net Shares Purchased (Sold) | -106.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KING STEVEN R. PH.D. Officer | -- | Direct | -- | Oct 8, 2024 |
| CONTE LISA A. Chief Executive Officer | -- | Direct | -- | Oct 8, 2024 |
| LIZAK CAROL R. Chief Financial Officer | -- | Direct | -- | Oct 8, 2024 |
| WOLIN JONATHAN S General Counsel | -- | Direct | -- | Oct 8, 2024 |
| CHATURVEDI PRAVIN R Officer | -- | Direct | -- | Oct 8, 2024 |
| KING STEVEN R. PH.D. Officer | -- | Direct | -- | May 17, 2024 |
| CONTE LISA A. Chief Executive Officer | -- | Direct | -- | May 17, 2024 |
| LIZAK CAROL R. Chief Financial Officer | -- | Direct | -- | May 17, 2024 |
| WOLIN JONATHAN S General Counsel | -- | Direct | -- | May 17, 2024 |
| CHATURVEDI PRAVIN R Officer | -- | Direct | -- | May 17, 2024 |
| KING STEVEN R. PH.D. Officer | -- | Direct | -- | Apr 5, 2024 |
| CONTE LISA A. Chief Executive Officer | -- | Direct | -- | Apr 5, 2024 |
| LIZAK CAROL R. Chief Financial Officer | -- | Direct | -- | Apr 5, 2024 |
| WOLIN JONATHAN S General Counsel | -- | Direct | -- | Apr 5, 2024 |
| CHATURVEDI PRAVIN R Officer | -- | Direct | -- | Apr 5, 2024 |
| BOCHNOWSKI JAMES J. Director | -- | Direct | -- | Aug 14, 2023 |
| MICEK JOHN J III Director | -- | Direct | -- | Aug 14, 2023 |
| KING STEVEN R. PH.D. Officer | -- | Direct | -- | Aug 14, 2023 |
| CONTE LISA A. Chief Executive Officer | -- | Direct | -- | Aug 14, 2023 |
| SIEGEL JONATHAN B Director | -- | Direct | -- | Aug 14, 2023 |
| LIZAK CAROL R. Chief Financial Officer | -- | Direct | -- | Aug 14, 2023 |
| WOLIN JONATHAN S General Counsel | -- | Direct | -- | Aug 14, 2023 |
| JAYASURIYA ANULA Director | -- | Direct | -- | Aug 14, 2023 |
| CHATURVEDI PRAVIN R Officer | -- | Direct | -- | Aug 14, 2023 |
| BOCHNOWSKI JAMES J. Director | -- | Direct | -- | May 17, 2023 |
| MICEK JOHN J III Director | -- | Direct | -- | May 17, 2023 |
| KING STEVEN R. PH.D. Officer | -- | Direct | -- | May 17, 2023 |
| CONTE LISA A. Chief Executive Officer | -- | Direct | -- | May 17, 2023 |
| SIEGEL JONATHAN B Director | -- | Direct | -- | May 17, 2023 |
| LIZAK CAROL R. Chief Financial Officer | -- | Direct | -- | May 17, 2023 |
| WOLIN JONATHAN S General Counsel | -- | Direct | -- | May 17, 2023 |
| CHATURVEDI PRAVIN R Officer | -- | Direct | -- | May 17, 2023 |
Related Tickers
PRTG Portage Biotech Inc.
10.76
-9.20%
BCTX BriaCell Therapeutics Corp.
4.1000
-8.07%
GLMD Galmed Pharmaceuticals Ltd.
1.2800
-2.29%
RGLS Regulus Therapeutics Inc.
7.85
-1.63%
AZTR Azitra, Inc.
0.3280
+1.49%
ENSC Ensysce Biosciences, Inc.
2.9700
-1.66%
CERO CERo Therapeutics Holdings, Inc.
0.8918
+0.21%
TVGN Tevogen Bio Holdings Inc.
0.9784
-5.01%
CGON CG Oncology, Inc.
27.74
+2.97%
TNXP Tonix Pharmaceuticals Holding Corp.
18.04
+0.17%